JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hagglund, R.
Right arrow Articles by Roizman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hagglund, R.
Right arrow Articles by Roizman, B.

 Previous Article  |  Next Article 

Journal of Virology, January 2002, p. 743-754, Vol. 76, No. 2
0022-538X/01/$04.00+0     DOI: 10.1128/JVI.76.2.743-754.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

US3 Protein Kinase of Herpes Simplex Virus 1 Blocks Caspase 3 Activation Induced by the Products of US1.5 and UL13 Genes and Modulates Expression of Transduced US1.5 Open Reading Frame in a Cell Type-Specific Manner

Ryan Hagglund, Joshua Munger, Alice P. W. Poon, and Bernard Roizman*

The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, Illinois 60637

Received 25 July 2001/ Accepted 11 October 2001

The coding domain of the herpes simplex virus type 1 (HSV-1) {alpha}22 gene encodes two proteins, the 420-amino-acid infected-cell protein 22 (ICP22) and US1.5, a protein colinear with the carboxyl-terminal domain of ICP22. In HSV-1-infected cells, ICP22 and US1.5 are extensively modified by the UL13 and US3 viral protein kinases. In this report, we show that in contrast to other viral proteins defined by their properties as {alpha} proteins, US1.5 becomes detectable and accumulated only at late times after infection. Moreover, significantly more US1.5 protein accumulated in cells infected with a mutant lacking the UL13 gene than in cells infected with wild-type virus. To define the role of viral protein kinases on the accumulation of US1.5 protein, rabbit skin cells or Vero cells were exposed to recombinant baculoviruses that expressed US1.5, UL13, or US3 proteins under a human cytomegalovirus immediate-early promoter. The results were as follows. (i) Accumulation of the US1.5 protein was reduced by concurrent expression of the UL13 protein kinase and augmented by concurrent expression of the US3 protein kinase. The magnitude of the reduction or increase in the accumulation of the US1.5 protein was cell type dependent. The effect of UL13 kinase appears to be specific inasmuch as it did not affect the accumulation of glycoprotein D in cells doubly infected by recombinant baculoviruses expressing these genes. (ii) The reduction in accumulation of the US1.5 protein was partially due to proteasome-dependent degradation. (iii) Both US1.5 and UL13 proteins activated caspase 3, indicative of programmed cell death. (iv) Concurrent expression of the US3 protein kinase blocked activation of caspase 3. The results are concordant with those published elsewhere (J. Munger and B. Roizman, Proc. Natl. Acad. Sci. USA 98:10410–10415, 2001) that the US3 protein kinase can block apoptosis by degradation or posttranslational modification of BAD.

* Corresponding author. Mailing address: The Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, 910 East 58th St., Chicago, IL 60637. Phone: (773) 702-1898. Fax: (773) 702-1631. E-mail: bernard{at}cummings.uchicago.edu.

Journal of Virology, January 2002, p. 743-754, Vol. 76, No. 2
0022-538X/01/$04.00+0     DOI: 10.1128/JVI.76.2.743-754.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.